GlobalData on MSN7h
Glaukos eyes FDA approval for ocular therapy after Phase III win
The company’s keratoconus medication, Epioxa, was effective in a Phase III trial, with plans to file for submission with the ...
ophthalmologytimes1d
Glaukos reports positive Phase 3 results for Epioxa
According to the company, in a confirmatory trial, Epioxa met pre-specified primary efficacy endpoint and exhibited positive ...
ophthalmologytimes2d
Oculis to present phase 3 DIAMOND program updates at Innovate Retina and Eyecelerator 2024
David Eichenbaum, MD and Riad Sherif, MD, CEO of Oculis will present the updates with additional info on topline results from ...
Oculis’ DIAMOND Phase 3 Program in Diabetic Macular Edema to be Presented at Innovate Retina and Eyecelerator 2024
About the Phase 3 DIAMOND Program of OCS-01 in Diabetic Macular Edema ...
Adverse effects found following faricimab treatment for eye conditions
Researchers led by the University Hospital Zurich have identified cases of sterile intraocular inflammation, including severe retinal vasculitis, associated with faricimab injections used to treat eye ...